APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vardenafil

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vardenafil Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchVardenafil Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vardenafil Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Vardenafil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vardenafil Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Vardenafil Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Vardenafil market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vardenafil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vardenafil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vardenafil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vardenafil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vardenafil include Teva, Zydus Pharmaceuticals, GSK, Bayer, Par Pharmaceutical, Macleods Pharmaceuticals, Crossmedika SA and Alembic Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vardenafil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vardenafil, also provides the sales of main regions and countries. Of the upcoming market potential for Vardenafil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vardenafil sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vardenafil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vardenafil sales, projected growth trends, production technology, application and end-user industry.

Vardenafil Segment by Company

Teva

Zydus Pharmaceuticals

GSK

Bayer

Par Pharmaceutical

Macleods Pharmaceuticals

Crossmedika SA

Alembic Pharmaceuticals

Vardenafil Segment by Type

5 mg Tablet

20 mg Tablet

2.5 mg Tablet

10 mg Tablet

Vardenafil Segment by Application

Hospital

Drug store

Vardenafil Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vardenafil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vardenafil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vardenafil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vardenafil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vardenafil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vardenafil sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vardenafil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Tablet Major Manufacturers Table 3. 20 mg Tablet Major Manufacturers Table 4. 2.5 mg Tablet Major Manufacturers Table 5. 10 mg Tablet Major Manufacturers Table 6. Global Vardenafil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Drug store Major Manufacturers Table 9. Vardenafil Industry Trends Table 10. Vardenafil Industry Drivers Table 11. Vardenafil Industry Opportunities and Challenges Table 12. Vardenafil Industry Restraints Table 13. Global Vardenafil Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Vardenafil Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Vardenafil Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Vardenafil Revenue Market Share by Region (2021-2026) Table 17. Global Vardenafil Revenue Market Share by Region (2027-2032) Table 18. Global Vardenafil Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Vardenafil Sales by Region (2021-2026) & (k units) Table 20. Global Vardenafil Sales by Region (2027-2032) & (k units) Table 21. Global Vardenafil Sales Market Share by Region (2021-2026) Table 22. Global Vardenafil Sales Market Share by Region (2027-2032) Table 23. Global Vardenafil Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Vardenafil Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Vardenafil Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Vardenafil Sales Market Share by Manufacturers (2021-2026) Table 27. Global Vardenafil Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Vardenafil Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Vardenafil Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Vardenafil Manufacturers, Product Type & Application Table 31. Global Vardenafil Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Vardenafil by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Vardenafil Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Vardenafil Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Vardenafil Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Vardenafil Revenue Market Share by Type (2021-2026) Table 38. Global Vardenafil Revenue Market Share by Type (2027-2032) Table 39. Global Vardenafil Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Vardenafil Sales by Type (2021-2026) & (k units) Table 41. Global Vardenafil Sales by Type (2027-2032) & (k units) Table 42. Global Vardenafil Sales Market Share by Type (2021-2026) Table 43. Global Vardenafil Sales Market Share by Type (2027-2032) Table 44. Global Vardenafil Price by Type (2021-2026) & (US$/unit) Table 45. Global Vardenafil Price by Type (2027-2032) & (US$/unit) Table 46. Global Vardenafil Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Vardenafil Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Vardenafil Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Vardenafil Revenue Market Share by Application (2021-2026) Table 50. Global Vardenafil Revenue Market Share by Application (2027-2032) Table 51. Global Vardenafil Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Vardenafil Sales by Application (2021-2026) & (k units) Table 53. Global Vardenafil Sales by Application (2027-2032) & (k units) Table 54. Global Vardenafil Sales Market Share by Application (2021-2026) Table 55. Global Vardenafil Sales Market Share by Application (2027-2032) Table 56. Global Vardenafil Price by Application (2021-2026) & (US$/unit) Table 57. Global Vardenafil Price by Application (2027-2032) & (US$/unit) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Teva Vardenafil Product Portfolio Table 62. Teva Recent Development Table 63. Zydus Pharmaceuticals Company Information Table 64. Zydus Pharmaceuticals Business Overview Table 65. Zydus Pharmaceuticals Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Zydus Pharmaceuticals Vardenafil Product Portfolio Table 67. Zydus Pharmaceuticals Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. GSK Vardenafil Product Portfolio Table 72. GSK Recent Development Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Bayer Vardenafil Product Portfolio Table 77. Bayer Recent Development Table 78. Par Pharmaceutical Company Information Table 79. Par Pharmaceutical Business Overview Table 80. Par Pharmaceutical Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Par Pharmaceutical Vardenafil Product Portfolio Table 82. Par Pharmaceutical Recent Development Table 83. Macleods Pharmaceuticals Company Information Table 84. Macleods Pharmaceuticals Business Overview Table 85. Macleods Pharmaceuticals Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Macleods Pharmaceuticals Vardenafil Product Portfolio Table 87. Macleods Pharmaceuticals Recent Development Table 88. Crossmedika SA Company Information Table 89. Crossmedika SA Business Overview Table 90. Crossmedika SA Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Crossmedika SA Vardenafil Product Portfolio Table 92. Crossmedika SA Recent Development Table 93. Alembic Pharmaceuticals Company Information Table 94. Alembic Pharmaceuticals Business Overview Table 95. Alembic Pharmaceuticals Vardenafil Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Alembic Pharmaceuticals Vardenafil Product Portfolio Table 97. Alembic Pharmaceuticals Recent Development Table 98. North America Vardenafil Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Vardenafil Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Vardenafil Sales by Type (2021-2026) & (k units) Table 101. North America Vardenafil Sales by Type (2027-2032) & (k units) Table 102. North America Vardenafil Sales Price by Type (2021-2026) & (US$/unit) Table 103. North America Vardenafil Sales Price by Type (2027-2032) & (US$/unit) Table 104. North America Vardenafil Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Vardenafil Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Vardenafil Sales by Application (2021-2026) & (k units) Table 107. North America Vardenafil Sales by Application (2027-2032) & (k units) Table 108. North America Vardenafil Sales Price by Application (2021-2026) & (US$/unit) Table 109. North America Vardenafil Sales Price by Application (2027-2032) & (US$/unit) Table 110. North America Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Vardenafil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Vardenafil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Vardenafil Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 114. North America Vardenafil Sales by Country (2021-2026) & (k units) Table 115. North America Vardenafil Sales by Country (2027-2032) & (k units) Table 116. North America Vardenafil Sales Price by Country (2021-2026) & (US$/unit) Table 117. North America Vardenafil Sales Price by Country (2027-2032) & (US$/unit) Table 118. United States Vardenafil Revenue (2021-2032) & (US$ Million) Table 119. Canada Vardenafil Revenue (2021-2032) & (US$ Million) Table 120. Mexico Vardenafil Revenue (2021-2032) & (US$ Million) Table 121. Europe Vardenafil Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Vardenafil Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Vardenafil Sales by Type (2021-2026) & (k units) Table 124. Europe Vardenafil Sales by Type (2027-2032) & (k units) Table 125. Europe Vardenafil Sales Price by Type (2021-2026) & (US$/unit) Table 126. Europe Vardenafil Sales Price by Type (2027-2032) & (US$/unit) Table 127. Europe Vardenafil Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Vardenafil Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Vardenafil Sales by Application (2021-2026) & (k units) Table 130. Europe Vardenafil Sales by Application (2027-2032) & (k units) Table 131. Europe Vardenafil Sales Price by Application (2021-2026) & (US$/unit) Table 132. Europe Vardenafil Sales Price by Application (2027-2032) & (US$/unit) Table 133. Europe Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Vardenafil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Vardenafil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Vardenafil Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 137. Europe Vardenafil Sales by Country (2021-2026) & (k units) Table 138. Europe Vardenafil Sales by Country (2027-2032) & (k units) Table 139. Europe Vardenafil Sales Price by Country (2021-2026) & (US$/unit) Table 140. Europe Vardenafil Sales Price by Country (2027-2032) & (US$/unit) Table 141. Germany Vardenafil Revenue (2021-2032) & (US$ Million) Table 142. France Vardenafil Revenue (2021-2032) & (US$ Million) Table 143. U.K. Vardenafil Revenue (2021-2032) & (US$ Million) Table 144. Italy Vardenafil Revenue (2021-2032) & (US$ Million) Table 145. Russia Vardenafil Revenue (2021-2032) & (US$ Million) Table 146. Spain Vardenafil Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Vardenafil Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Vardenafil Revenue (2021-2032) & (US$ Million) Table 149. Sweden Vardenafil Revenue (2021-2032) & (US$ Million) Table 150. Poland Vardenafil Revenue (2021-2032) & (US$ Million) Table 151. China Vardenafil Revenue by Type (2021-2026) & (US$ Million) Table 152. China Vardenafil Revenue by Type (2027-2032) & (US$ Million) Table 153. China Vardenafil Sales by Type (2021-2026) & (k units) Table 154. China Vardenafil Sales by Type (2027-2032) & (k units) Table 155. China Vardenafil Sales Price by Type (2021-2026) & (US$/unit) Table 156. China Vardenafil Sales Price by Type (2027-2032) & (US$/unit) Table 157. China Vardenafil Revenue by Application (2021-2026) & (US$ Million) Table 158. China Vardenafil Revenue by Application (2027-2032) & (US$ Million) Table 159. China Vardenafil Sales by Application (2021-2026) & (k units) Table 160. China Vardenafil Sales by Application (2027-2032) & (k units) Table 161. China Vardenafil Sales Price by Application (2021-2026) & (US$/unit) Table 162. China Vardenafil Sales Price by Application (2027-2032) & (US$/unit) Table 163. Asia Vardenafil Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Vardenafil Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Vardenafil Sales by Type (2021-2026) & (k units) Table 166. Asia Vardenafil Sales by Type (2027-2032) & (k units) Table 167. Asia Vardenafil Sales Price by Type (2021-2026) & (US$/unit) Table 168. Asia Vardenafil Sales Price by Type (2027-2032) & (US$/unit) Table 169. Asia Vardenafil Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Vardenafil Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Vardenafil Sales by Application (2021-2026) & (k units) Table 172. Asia Vardenafil Sales by Application (2027-2032) & (k units) Table 173. Asia Vardenafil Sales Price by Application (2021-2026) & (US$/unit) Table 174. Asia Vardenafil Sales Price by Application (2027-2032) & (US$/unit) Table 175. Asia Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Vardenafil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Vardenafil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Vardenafil Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 179. Asia Vardenafil Sales by Country (2021-2026) & (k units) Table 180. Asia Vardenafil Sales by Country (2027-2032) & (k units) Table 181. Asia Vardenafil Sales Price by Country (2021-2026) & (US$/unit) Table 182. Asia Vardenafil Sales Price by Country (2027-2032) & (US$/unit) Table 183. Japan Vardenafil Revenue (2021-2032) & (US$ Million) Table 184. South Korea Vardenafil Revenue (2021-2032) & (US$ Million) Table 185. India Vardenafil Revenue (2021-2032) & (US$ Million) Table 186. Australia Vardenafil Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Vardenafil Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Vardenafil Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Vardenafil Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Vardenafil Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Vardenafil Sales by Type (2021-2026) & (k units) Table 192. SAMEA Vardenafil Sales by Type (2027-2032) & (k units) Table 193. SAMEA Vardenafil Sales Price by Type (2021-2026) & (US$/unit) Table 194. SAMEA Vardenafil Sales Price by Type (2027-2032) & (US$/unit) Table 195. SAMEA Vardenafil Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Vardenafil Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Vardenafil Sales by Application (2021-2026) & (k units) Table 198. SAMEA Vardenafil Sales by Application (2027-2032) & (k units) Table 199. SAMEA Vardenafil Sales Price by Application (2021-2026) & (US$/unit) Table 200. SAMEA Vardenafil Sales Price by Application (2027-2032) & (US$/unit) Table 201. SAMEA Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Vardenafil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Vardenafil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Vardenafil Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 205. SAMEA Vardenafil Sales by Country (2021-2026) & (k units) Table 206. SAMEA Vardenafil Sales by Country (2027-2032) & (k units) Table 207. SAMEA Vardenafil Sales Price by Country (2021-2026) & (US$/unit) Table 208. SAMEA Vardenafil Sales Price by Country (2027-2032) & (US$/unit) Table 209. Brazil Vardenafil Revenue (2021-2032) & (US$ Million) Table 210. Argentina Vardenafil Revenue (2021-2032) & (US$ Million) Table 211. Chile Vardenafil Revenue (2021-2032) & (US$ Million) Table 212. Colombia Vardenafil Revenue (2021-2032) & (US$ Million) Table 213. Peru Vardenafil Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Vardenafil Revenue (2021-2032) & (US$ Million) Table 215. Israel Vardenafil Revenue (2021-2032) & (US$ Million) Table 216. UAE Vardenafil Revenue (2021-2032) & (US$ Million) Table 217. Turkey Vardenafil Revenue (2021-2032) & (US$ Million) Table 218. Iran Vardenafil Revenue (2021-2032) & (US$ Million) Table 219. Egypt Vardenafil Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Vardenafil Distributors List Table 223. Vardenafil Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Vardenafil Image Figure 2. Global Vardenafil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vardenafil Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Tablet Image Figure 5. 20 mg Tablet Image Figure 6. 2.5 mg Tablet Image Figure 7. 10 mg Tablet Image Figure 8. Global Vardenafil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Vardenafil Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Drug store Image Figure 12. Global Vardenafil Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Vardenafil Revenue (2021-2032) & (US$ Million) Figure 14. Global Vardenafil Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Vardenafil Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Vardenafil Revenue Market Share by Region (2021-2032) Figure 17. Global Vardenafil Sales (2021-2032) & (k units) Figure 18. Global Vardenafil Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Vardenafil Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Vardenafil Sales YoY (2021-2032) & (k units) Figure 21. Europe Vardenafil Sales YoY (2021-2032) & (k units) Figure 22. China Vardenafil Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Vardenafil Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Vardenafil Sales YoY (2021-2032) & (k units) Figure 25. Global Vardenafil Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Vardenafil Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Vardenafil Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Vardenafil Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Vardenafil Revenue Market Share by Type (2021-2032) Figure 31. Global Vardenafil Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Vardenafil Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Vardenafil Sales Market Share by Type (2021-2032) Figure 34. Global Vardenafil Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Vardenafil Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Vardenafil Revenue Market Share by Application (2021-2032) Figure 37. Global Vardenafil Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Vardenafil Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Vardenafil Sales Market Share by Application (2021-2032) Figure 40. North America Vardenafil Revenue Share by Type (2021-2032) Figure 41. North America Vardenafil Sales Share by Type (2021-2032) Figure 42. North America Vardenafil Revenue Share by Application (2021-2032) Figure 43. North America Vardenafil Sales Share by Application (2021-2032) Figure 44. North America Vardenafil Revenue Share by Country (2021-2032) Figure 45. North America Vardenafil Sales Share by Country (2021-2032) Figure 46. Europe Vardenafil Revenue Share by Type (2021-2032) Figure 47. Europe Vardenafil Sales Share by Type (2021-2032) Figure 48. Europe Vardenafil Revenue Share by Application (2021-2032) Figure 49. Europe Vardenafil Sales Share by Application (2021-2032) Figure 50. Europe Vardenafil Revenue Share by Country (2021-2032) Figure 51. Europe Vardenafil Sales Share by Country (2021-2032) Figure 52. China Vardenafil Revenue Share by Type (2021-2032) Figure 53. China Vardenafil Sales Share by Type (2021-2032) Figure 54. China Vardenafil Revenue Share by Application (2021-2032) Figure 55. China Vardenafil Sales Share by Application (2021-2032) Figure 56. Asia Vardenafil Revenue Share by Type (2021-2032) Figure 57. Asia Vardenafil Sales Share by Type (2021-2032) Figure 58. Asia Vardenafil Revenue Share by Application (2021-2032) Figure 59. Asia Vardenafil Sales Share by Application (2021-2032) Figure 60. Asia Vardenafil Revenue Share by Country (2021-2032) Figure 61. Asia Vardenafil Sales Share by Country (2021-2032) Figure 62. SAMEA Vardenafil Revenue Share by Type (2021-2032) Figure 63. SAMEA Vardenafil Sales Share by Type (2021-2032) Figure 64. SAMEA Vardenafil Revenue Share by Application (2021-2032) Figure 65. SAMEA Vardenafil Sales Share by Application (2021-2032) Figure 66. SAMEA Vardenafil Revenue Share by Country (2021-2032) Figure 67. SAMEA Vardenafil Sales Share by Country (2021-2032) Figure 68. Vardenafil Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Vardenafil Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Tablet
  • 20 mg Tablet
  • 2.5 mg Tablet
  • 10 mg Tablet
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Zydus Pharmaceuticals
  • GSK
  • Bayer
  • Par Pharmaceutical
  • Macleods Pharmaceuticals
  • Crossmedika SA
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vardenafil Market by Type
  3. 1.2.1 Global Vardenafil Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg Tablet
  5. 1.2.3 20 mg Tablet
  6. 1.2.4 2.5 mg Tablet
  7. 1.2.5 10 mg Tablet
  8. 1.3 Vardenafil Market by Application
  9. 1.3.1 Global Vardenafil Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Drug store
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Vardenafil Market Dynamics
  1. 2.1 Vardenafil Industry Trends
  2. 2.2 Vardenafil Industry Drivers
  3. 2.3 Vardenafil Industry Opportunities and Challenges
  4. 2.4 Vardenafil Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vardenafil Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vardenafil Revenue by Region
  3. 3.2.1 Global Vardenafil Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vardenafil Revenue by Region (2021-2026)
  5. 3.2.3 Global Vardenafil Revenue by Region (2027-2032)
  6. 3.2.4 Global Vardenafil Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vardenafil Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vardenafil Sales by Region
  9. 3.4.1 Global Vardenafil Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vardenafil Sales by Region (2021-2026)
  11. 3.4.3 Global Vardenafil Sales by Region (2027-2032)
  12. 3.4.4 Global Vardenafil Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vardenafil Revenue by Manufacturers
  2. 4.1.1 Global Vardenafil Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vardenafil Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vardenafil Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vardenafil Sales by Manufacturers
  6. 4.2.1 Global Vardenafil Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vardenafil Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vardenafil Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vardenafil Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vardenafil Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vardenafil Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vardenafil Manufacturers, Product Type & Application
  13. 4.7 Global Vardenafil Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vardenafil Market CR5 and HHI
  16. 4.8.2 2025 Vardenafil Tier 1, Tier 2, and Tier 3
5 Vardenafil Market by Type
  1. 5.1 Global Vardenafil Revenue by Type
  2. 5.1.1 Global Vardenafil Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vardenafil Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vardenafil Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vardenafil Sales by Type
  6. 5.2.1 Global Vardenafil Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vardenafil Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Vardenafil Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vardenafil Price by Type
6 Vardenafil Market by Application
  1. 6.1 Global Vardenafil Revenue by Application
  2. 6.1.1 Global Vardenafil Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vardenafil Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vardenafil Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vardenafil Sales by Application
  6. 6.2.1 Global Vardenafil Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vardenafil Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Vardenafil Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vardenafil Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Vardenafil Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Zydus Pharmaceuticals
  8. 7.2.1 Zydus Pharmaceuticals Company Information
  9. 7.2.2 Zydus Pharmaceuticals Business Overview
  10. 7.2.3 Zydus Pharmaceuticals Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zydus Pharmaceuticals Vardenafil Product Portfolio
  12. 7.2.5 Zydus Pharmaceuticals Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Vardenafil Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Vardenafil Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 Par Pharmaceutical
  26. 7.5.1 Par Pharmaceutical Company Information
  27. 7.5.2 Par Pharmaceutical Business Overview
  28. 7.5.3 Par Pharmaceutical Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Par Pharmaceutical Vardenafil Product Portfolio
  30. 7.5.5 Par Pharmaceutical Recent Developments
  31. 7.6 Macleods Pharmaceuticals
  32. 7.6.1 Macleods Pharmaceuticals Company Information
  33. 7.6.2 Macleods Pharmaceuticals Business Overview
  34. 7.6.3 Macleods Pharmaceuticals Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Macleods Pharmaceuticals Vardenafil Product Portfolio
  36. 7.6.5 Macleods Pharmaceuticals Recent Developments
  37. 7.7 Crossmedika SA
  38. 7.7.1 Crossmedika SA Company Information
  39. 7.7.2 Crossmedika SA Business Overview
  40. 7.7.3 Crossmedika SA Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Crossmedika SA Vardenafil Product Portfolio
  42. 7.7.5 Crossmedika SA Recent Developments
  43. 7.8 Alembic Pharmaceuticals
  44. 7.8.1 Alembic Pharmaceuticals Company Information
  45. 7.8.2 Alembic Pharmaceuticals Business Overview
  46. 7.8.3 Alembic Pharmaceuticals Vardenafil Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Alembic Pharmaceuticals Vardenafil Product Portfolio
  48. 7.8.5 Alembic Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Vardenafil Market Size by Type
  2. 8.1.1 North America Vardenafil Revenue by Type (2021-2032)
  3. 8.1.2 North America Vardenafil Sales by Type (2021-2032)
  4. 8.1.3 North America Vardenafil Price by Type (2021-2032)
  5. 8.2 North America Vardenafil Market Size by Application
  6. 8.2.1 North America Vardenafil Revenue by Application (2021-2032)
  7. 8.2.2 North America Vardenafil Sales by Application (2021-2032)
  8. 8.2.3 North America Vardenafil Price by Application (2021-2032)
  9. 8.3 North America Vardenafil Market Size by Country
  10. 8.3.1 North America Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vardenafil Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vardenafil Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Vardenafil Market Size by Type
  2. 9.1.1 Europe Vardenafil Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vardenafil Sales by Type (2021-2032)
  4. 9.1.3 Europe Vardenafil Price by Type (2021-2032)
  5. 9.2 Europe Vardenafil Market Size by Application
  6. 9.2.1 Europe Vardenafil Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vardenafil Sales by Application (2021-2032)
  8. 9.2.3 Europe Vardenafil Price by Application (2021-2032)
  9. 9.3 Europe Vardenafil Market Size by Country
  10. 9.3.1 Europe Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vardenafil Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vardenafil Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Vardenafil Market Size by Type
  2. 10.1.1 China Vardenafil Revenue by Type (2021-2032)
  3. 10.1.2 China Vardenafil Sales by Type (2021-2032)
  4. 10.1.3 China Vardenafil Price by Type (2021-2032)
  5. 10.2 China Vardenafil Market Size by Application
  6. 10.2.1 China Vardenafil Revenue by Application (2021-2032)
  7. 10.2.2 China Vardenafil Sales by Application (2021-2032)
  8. 10.2.3 China Vardenafil Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vardenafil Market Size by Type
  2. 11.1.1 Asia Vardenafil Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vardenafil Sales by Type (2021-2032)
  4. 11.1.3 Asia Vardenafil Price by Type (2021-2032)
  5. 11.2 Asia Vardenafil Market Size by Application
  6. 11.2.1 Asia Vardenafil Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vardenafil Sales by Application (2021-2032)
  8. 11.2.3 Asia Vardenafil Price by Application (2021-2032)
  9. 11.3 Asia Vardenafil Market Size by Country
  10. 11.3.1 Asia Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vardenafil Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vardenafil Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vardenafil Market Size by Type
  2. 12.1.1 SAMEA Vardenafil Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vardenafil Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vardenafil Price by Type (2021-2032)
  5. 12.2 SAMEA Vardenafil Market Size by Application
  6. 12.2.1 SAMEA Vardenafil Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vardenafil Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vardenafil Price by Application (2021-2032)
  9. 12.3 SAMEA Vardenafil Market Size by Country
  10. 12.3.1 SAMEA Vardenafil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vardenafil Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vardenafil Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vardenafil Value Chain Analysis
  2. 13.1.1 Vardenafil Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vardenafil Production Mode & Process
  6. 13.2 Vardenafil Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vardenafil Distributors
  9. 13.2.3 Vardenafil Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst